Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight

New York, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight According to DelveInsight’s analysis,...
September 23, 2025 13:00 ET | Source: DelveInsight Business Research LLP

TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The TGF-β...
September 16, 2025 12:10 ET | Source: Quetzal Therapeutics

Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer

Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
September 09, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight

New York, USA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight The...
August 05, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Global Chronic Obstructive Pulmonary Disease Treatment Devices Market to Witness Growth at a CAGR of ~6% by 2032 | DelveInsight

New York, USA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Global Chronic Obstructive Pulmonary Disease Treatment Devices Market to Witness Growth at a CAGR of ~6% by 2032 | DelveInsightThe market for chronic...
July 28, 2025 08:45 ET | Source: Aclaris Therapeutics, Inc.

Aclaris Therapeutics Announces Leadership Transition

Aclaris Therapeutics Announces Scientific Leadership Transition
July 10, 2025 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing...
July 01, 2025 16:01 ET | Source: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer

MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new...
May 06, 2025 04:00 ET | Source: ENA Respiratory

ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer

MELBOURNE, Australia, May 06, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral...
April 21, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight

New York, USA, April 21, 2025 (GLOBE NEWSWIRE) -- Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and...